WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke CBDSTRIPS wurde als Wortmarke am 31.10.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1504779 |
| Länder | 
|
| Basismarke |
Nr. 1960709,
02. Mai 2019
|
| Anmeldedatum | 31. Oktober 2019 |
| Ablaufdatum | 31. Oktober 2029 |
Markeninhaber
1130 Pender Street West, Suite 820
Vancouver BC V6E 4A4
CA
Vancouver BC V6E 4A4
CA
Markenvertreter
Bentall, 550 Burrard Street,
Suite 2300, P.O. Box 30
CA
Waren und Dienstleistungen
05
Pharmaceutical preparations for the treatment of
post-traumatic stress disorder (PTSD), anxiety, sleep,
digestive disorders, namely gastric hyperactivity,
gastroenteritis, nausea, gastric and stomach ulcers,
intestinal inflammation, acid reflux, intestinal motility
disorders, and enteritis, sexual disorders, namely, female
sexual dysfunction (FSD) and erectile dysfunction (ED), low
libido in both sexes, and nutrition disorders, namely
mineral deficiency, vitamin deficiency and pain relief;
chemical preparations for pharmaceutical and medical
purposes, namely, for post-traumatic stress disorder (PTSD),
anxiety, sleep, digestive, sexual and nutrition disorders
and pain relief; medicinal herbal preparations for medical
purposes, namely medical cannabis and marijuana extracts;
medicinal preparations, namely medical cannabis and
marijuana extracts, for oral consumption, namely medical
cannabis and marijuana extracts in the form of drops,
capsules, tablets and compressed tablets; plant extracts for
pharmaceutical purposes, namely medical cannabis and
marijuana extracts; plant extracts for medical, veterinary
and pharmaceutical purposes, namely medical cannabis and
marijuana extracts; pharmaceutical preparations, namely,
antivirals; pharmaceutical preparations for the prevention
and treatment of cancer; pharmaceutical preparations for the
treatment of joint disease; pharmaceutical products for
treating respiratory diseases; pharmaceuticals for the
treatment of erectile dysfunction; digestives for
pharmaceutical purposes, namely pharmaceutical preparations
for the treatment of gastric hyperactivity, gastroenteritis,
nausea, gastric and stomach ulcers, intestinal inflammation,
intestinal motility disorders acid reflux, and enteritis;
sexual stimulant gels
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 23. Dezember 2020 | 2020/52 Gaz | GB | Ablehnung |
| 22. Dezember 2020 | 2021/1 Gaz | DE | Ablehnung |
| 30. Oktober 2020 | 2020/45 Gaz | ES | Ablehnung |
| 27. August 2020 | 2020/36 Gaz | GB | Ablehnung |
| 17. Juni 2020 | 2020/25 Gaz | ES | Ablehnung |
| 29. April 2020 | 2020/27 Gaz | DE | Ablehnung |
| 31. Oktober 2019 | 2019/49 Gaz | CA | Eintragung |
ID: 141504779